Robeco Institutional Asset Management B.V. Neurocrine Biosciences Inc Transaction History
Robeco Institutional Asset Management B.V.
- $66.7 Billion
- Q3 2025
A detailed history of Robeco Institutional Asset Management B.V. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 28,185 shares of NBIX stock, worth $4.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,185
Previous 15,098
86.68%
Holding current value
$4.04 Million
Previous $1.9 Million
108.54%
% of portfolio
0.01%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding NBIX
# of Institutions
693Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$797 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$640 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$442 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...